Recipharm completes refinancing, extends debt maturities by seven years

Bitget2026/10/27 09:24

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Recipharm completed a refinancing that extends its debt maturity profile by seven years, supporting continued investment in specialist capabilities.
Moody's Ratings assigned a B2 Corporate Family Rating with a stable outlook, improving its credit assessment.
S&P Global Ratings assigned Recipharm Holding a long-term issuer credit rating of B with a stable outlook, an improvement.
Fitch affirmed its Long-Term Issuer Default Rating of B with a stable outlook.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recipharm AB published the original content used to generate this news brief on October 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Recipharm completes refinancing, extends debt maturities by seven years

You may also like

Crypto prices